FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis

Background: Fibroblast growth factor-23 (FGF-23) is a hormone principally produced by osteocytes/osteoblasts. In patients with chronic kidney disease (CKD), FGF-23 levels are usually elevated and can reach up to 300 – 400 times the normal range. FGF-23 is regulated by local bone-related and systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Florence, El-Husseini, Amr, Monier-Faugere, Marie-Claude, David, Valentin, Mawad, Hanna, Quarles, Darryl, Malluche, Hartmut H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535177/
https://www.ncbi.nlm.nih.gov/pubmed/25208316
http://dx.doi.org/10.5414/CN108407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535177/
https://www.ncbi.nlm.nih.gov/pubmed/25208316
http://dx.doi.org/10.5414/CN108407

Ejemplares similares